BioSenic

{
  "facts": [
    {
      "type": "filing",
      "quote": "21 MAI 2026",
      "value": "2026-05-21",
      "object": null,
      "subject": "e1"
    },
    {
      "type": "general_meeting",
      "quote": "Extrait du proc\u00E8s-verbal de la r\u00E9union du conseil d\u0027administration de BioSenic SA (la \u0022Soci\u00E9t\u00E9\u0022) du 28 avril 2026",
      "value": "2026-04-28",
      "object": null,
      "subject": "e1"
    },
    {
      "type": "officer_resignation",
      "quote": "PRENNENT ACTE de la d\u00E9mission d\u0027Iryl Partners SAS, repr\u00E9sent\u00E9e par son repr\u00E9sentant permanent Madame Revital Rattenbach (Aflalo), en tant qu\u0027administrateur de la Soci\u00E9t\u00E9, avec effet au 29 janvier 2026.",
      "value": {
        "date": "2026-01-29",
        "role": "administrateur"
      },
      "object": "e1",
      "subject": "e2"
    },
    {
      "type": "permanent_representative",
      "quote": "PRENNENT ACTE de la d\u00E9mission d\u0027Iryl Partners SAS, repr\u00E9sent\u00E9e par son repr\u00E9sentant permanent Madame Revital Rattenbach (Aflalo), en tant qu\u0027administrateur de la Soci\u00E9t\u00E9, avec effet au 29 janvier 2026.",
      "value": {
        "date": "2026-01-29",
        "role": "repr\u00E9sentant permanent",
        "status": "terminated"
      },
      "object": "e2",
      "subject": "e3"
    },
    {
      "type": "permanent_representative",
      "quote": "PRENNENT ACTE que le mandat de Monsieur Jean-Fran\u00E7ois Rax en tant que repr\u00E9sentant permanent de l\u0027administrateur de la Soci\u00E9t\u00E9, Capital Grand Est SAS, a pris fin au 29 janvier 2026.",
      "value": {
        "date": "2026-01-29",
        "role": "repr\u00E9sentant permanent",
        "status": "terminated"
      },
      "object": "e4",
      "subject": "e5"
    },
    {
      "type": "permanent_representative",
      "quote": "PRENNENT ACTE que, conform\u00E9ment \u00E0 l\u0027article 2:55 du CSA, Capital Grand Est SAS, en qualit\u00E9 d\u0027administrateur de la Soci\u00E9t\u00E9, a d\u00E9sign\u00E9 Madame Virginie Miath, \u00E9lisant domicile pour toutes les questions relatives \u00E0 son mandat d\u0027administrateur au si\u00E8ge de la Soci\u00E9t\u00E9, comme son nouveau repr\u00E9sentant permanent avec effet \u00E0 compter du 29 janvier 2026 pour la dur\u00E9e restant \u00E0 courir du mandat.",
      "value": {
        "date": "2026-01-29",
        "role": "repr\u00E9sentant permanent",
        "status": "appointed"
      },
      "object": "e4",
      "subject": "e6"
    },
    {
      "type": "power_of_attorney",
      "quote": "D\u00C9CIDENT d\u0027accorder \u00E0 Hadrien Chef et Shahine Rezaei Kalantari, avocats, et Sofia Ballesteros Garcia, paralegal, ayant leur bureau \u00E0 1000 Bruxelles, Bastion Tower, Place du Champ de Mars 5, ou tout autre avocat ou paralegal du cabinet Osborne Clarke BV/SRL, officiant depuis la m\u00EAme adresse, chacun agissant seul et avec pouvoir de substitution, le pouvoir d\u0027agir au nom de la Soci\u00E9t\u00E9 afin de se conformer aux exigences l\u00E9gales r\u00E9sultant des pr\u00E9sentes r\u00E9solutions, et en particulier la publication d\u0027un extrait des r\u00E9solutions pertinentes aux Annexes du Moniteur belge et la mise \u00E0 jour des informations d\u0027enregistrement de la Soci\u00E9t\u00E9 au registre des personnes morales de la Banque-Carrefour des Entreprises.",
      "value": {
        "date": "2026-04-28",
        "scope": "agir au nom de la Soci\u00E9t\u00E9 afin de se conformer aux exigences l\u00E9gales r\u00E9sultant des pr\u00E9sentes r\u00E9solutions, et en particulier la publication d\u0027un extrait des r\u00E9solutions pertinentes aux Annexes du Moniteur belge et la mise \u00E0 jour des informations d\u0027enregistrement de la Soci\u00E9t\u00E9 au registre des personnes morales de la Banque-Carrefour des Entreprises.",
        "granted_by": "conseil d\u0027administration"
      },
      "object": "e7",
      "subject": "e1"
    },
    {
      "type": "power_of_attorney",
      "quote": "D\u00C9CIDENT d\u0027accorder \u00E0 Hadrien Chef et Shahine Rezaei Kalantari, avocats, et Sofia Ballesteros Garcia, paralegal, ayant leur bureau \u00E0 1000 Bruxelles, Bastion Tower, Place du Champ de Mars 5, ou tout autre avocat ou paralegal du cabinet Osborne Clarke BV/SRL, officiant depuis la m\u00EAme adresse, chacun agissant seul et avec pouvoir de substitution, le pouvoir d\u0027agir au nom de la Soci\u00E9t\u00E9 afin de se conformer aux exigences l\u00E9gales r\u00E9sultant des pr\u00E9sentes r\u00E9solutions, et en particulier la publication d\u0027un extrait des r\u00E9solutions pertinentes aux Annexes du Moniteur belge et la mise \u00E0 jour des informations d\u0027enregistrement de la Soci\u00E9t\u00E9 au registre des personnes morales de la Banque-Carrefour des Entreprises.",
      "value": {
        "date": "2026-04-28",
        "scope": "agir au nom de la Soci\u00E9t\u00E9 afin de se conformer aux exigences l\u00E9gales r\u00E9sultant des pr\u00E9sentes r\u00E9solutions, et en particulier la publication d\u0027un extrait des r\u00E9solutions pertinentes aux Annexes du Moniteur belge et la mise \u00E0 jour des informations d\u0027enregistrement de la Soci\u00E9t\u00E9 au registre des personnes morales de la Banque-Carrefour des Entreprises.",
        "granted_by": "conseil d\u0027administration"
      },
      "object": "e8",
      "subject": "e1"
    },
    {
      "type": "power_of_attorney",
      "quote": "D\u00C9CIDENT d\u0027accorder \u00E0 Hadrien Chef et Shahine Rezaei Kalantari, avocats, et Sofia Ballesteros Garcia, paralegal, ayant leur bureau \u00E0 1000 Bruxelles, Bastion Tower, Place du Champ de Mars 5, ou tout autre avocat ou paralegal du cabinet Osborne Clarke BV/SRL, officiant depuis la m\u00EAme adresse, chacun agissant seul et avec pouvoir de substitution, le pouvoir d\u0027agir au nom de la Soci\u00E9t\u00E9 afin de se conformer aux exigences l\u00E9gales r\u00E9sultant des pr\u00E9sentes r\u00E9solutions, et en particulier la publication d\u0027un extrait des r\u00E9solutions pertinentes aux Annexes du Moniteur belge et la mise \u00E0 jour des informations d\u0027enregistrement de la Soci\u00E9t\u00E9 au registre des personnes morales de la Banque-Carrefour des Entreprises.",
      "value": {
        "date": "2026-04-28",
        "scope": "agir au nom de la Soci\u00E9t\u00E9 afin de se conformer aux exigences l\u00E9gales r\u00E9sultant des pr\u00E9sentes r\u00E9solutions, et en particulier la publication d\u0027un extrait des r\u00E9solutions pertinentes aux Annexes du Moniteur belge et la mise \u00E0 jour des informations d\u0027enregistrement de la Soci\u00E9t\u00E9 au registre des personnes morales de la Banque-Carrefour des Entreprises.",
        "granted_by": "conseil d\u0027administration"
      },
      "object": "e9",
      "subject": "e1"
    },
    {
      "type": "power_of_attorney",
      "quote": "D\u00C9CIDENT d\u0027accorder \u00E0 Hadrien Chef et Shahine Rezaei Kalantari, avocats, et Sofia Ballesteros Garcia, paralegal, ayant leur bureau \u00E0 1000 Bruxelles, Bastion Tower, Place du Champ de Mars 5, ou tout autre avocat ou paralegal du cabinet Osborne Clarke BV/SRL, officiant depuis la m\u00EAme adresse, chacun agissant seul et avec pouvoir de substitution, le pouvoir d\u0027agir au nom de la Soci\u00E9t\u00E9 afin de se conformer aux exigences l\u00E9gales r\u00E9sultant des pr\u00E9sentes r\u00E9solutions, et en particulier la publication d\u0027un extrait des r\u00E9solutions pertinentes aux Annexes du Moniteur belge et la mise \u00E0 jour des informations d\u0027enregistrement de la Soci\u00E9t\u00E9 au registre des personnes morales de la Banque-Carrefour des Entreprises.",
      "value": {
        "date": "2026-04-28",
        "scope": "agir au nom de la Soci\u00E9t\u00E9 afin de se conformer aux exigences l\u00E9gales r\u00E9sultant des pr\u00E9sentes r\u00E9solutions, et en particulier la publication d\u0027un extrait des r\u00E9solutions pertinentes aux Annexes du Moniteur belge et la mise \u00E0 jour des informations d\u0027enregistrement de la Soci\u00E9t\u00E9 au registre des personnes morales de la Banque-Carrefour des Entreprises.",
        "granted_by": "conseil d\u0027administration"
      },
      "object": "e10",
      "subject": "e1"
    },
    {
      "type": "publication",
      "quote": "Belgisch Staatsblad - 03/06/2026",
      "value": "2026-06-03",
      "object": null,
      "subject": null
    },
    {
      "type": "act_object",
      "quote": "Objet de l\u0027acte: D\u00E9mission d\u0027administrateur et remplacement de repr\u00E9sentant permanent",
      "value": "D\u00E9mission d\u0027administrateur et remplacement de repr\u00E9sentant permanent",
      "object": null,
      "subject": null
    }
  ],
  "act_meta": {
    "model_id": 40,
    "extractor": "open-capture-27b-v3",
    "ocr_chars": 2871,
    "truncated": false,
    "needs_verify": false
  },
  "entities": [
    {
      "id": "e1",
      "kbo": "0882.015.654",
      "kind": "company",
      "name": "BioSenic SA",
      "attrs": {
        "address": "Avenue L\u00E9on Champagne 3, 1480 Saintes (Tubize)",
        "legal_form": "Soci\u00E9t\u00E9 anonyme"
      }
    },
    {
      "id": "e2",
      "kbo": null,
      "kind": "org",
      "name": "Iryl Partners SAS",
      "attrs": {}
    },
    {
      "id": "e3",
      "kbo": null,
      "kind": "person",
      "name": "Revital Rattenbach (Aflalo)",
      "attrs": {}
    },
    {
      "id": "e4",
      "kbo": null,
      "kind": "org",
      "name": "Capital Grand Est SAS",
      "attrs": {}
    },
    {
      "id": "e5",
      "kbo": null,
      "kind": "person",
      "name": "Jean-Fran\u00E7ois Rax",
      "attrs": {}
    },
    {
      "id": "e6",
      "kbo": null,
      "kind": "person",
      "name": "Virginie Miath",
      "attrs": {}
    },
    {
      "id": "e7",
      "kbo": null,
      "kind": "person",
      "name": "Hadrien Chef",
      "attrs": {}
    },
    {
      "id": "e8",
      "kbo": null,
      "kind": "person",
      "name": "Shahine Rezaei Kalantari",
      "attrs": {}
    },
    {
      "id": "e9",
      "kbo": null,
      "kind": "person",
      "name": "Sofia Ballesteros Garcia",
      "attrs": {}
    },
    {
      "id": "e10",
      "kbo": null,
      "kind": "org",
      "name": "Osborne Clarke BV/SRL",
      "attrs": {}
    }
  ]
}

{
  "stage": null,
  "notary": {
    "name": "Peter VAN MELKEBEKE",
    "firm_city": null,
    "firm_name": "Berquin Notaires",
    "office_city": "Bruxelles",
    "is_associated": true
  },
  "act_meta": {
    "language": "fr",
    "pub_date": "2026-04-20",
    "filing_date": "2026-04-16",
    "act_kind_objet": "DIVERS"
  },
  "decision": {
    "body": "raad_van_bestuur",
    "act_date": "2026-04-10",
    "unanimous": null
  },
  "conversion": null,
  "detected_kind": "other",
  "report_waiver": null,
  "restructuring": {
    "parties": [
      {
        "kbo": "0882.015.654",
        "name": "BioSenic",
        "role": "other",
        "address": "Avenue L\u00E9on Champagne 3, 1480 Tubize",
        "is_foreign": false,
        "legal_form": "Soci\u00E9t\u00E9 anonyme",
        "is_new_company": false,
        "jurisdiction_country": null
      }
    ],
    "exchange_ratio": null,
    "legal_articles": [
      "7:180",
      "7:191",
      "7:198"
    ],
    "is_cross_border": false,
    "is_silent_merger": false,
    "balance_basis_date": null,
    "exchange_ratio_text": null,
    "new_shares_issued_n": 0,
    "real_estate_included": false,
    "patrimony_description": "L\u0027op\u00E9ration ne concerne pas le transfert d\u0027un patrimoine, mais l\u0027\u00E9mission de droits de souscription et une augmentation de capital en num\u00E9raire sous condition suspensive.",
    "equity_transferred_eur": null,
    "accounting_effective_date": null
  },
  "subject_company": {
    "kbo": "0882.015.654",
    "name_full": "BioSenic",
    "legal_form": "Soci\u00E9t\u00E9 anonyme"
  },
  "publication_proxy": {
    "kind": "person",
    "org_kbo": null,
    "org_name": null,
    "person_name": "Peter VAN MELKEBEKE",
    "org_rep_person_name": null
  },
  "summary_narrative": "Le conseil d\u0027administration de BioSenic, r\u00E9uni en visioconf\u00E9rence, a pris plusieurs d\u00E9cisions le 10 avril 2026 : il a approuv\u00E9 le rapport du commissaire, a d\u00E9cid\u00E9 de l\u0027\u00E9mission de 130.572.455 droits de souscription dans le cadre du Plan de Droits de Souscription 2026, a supprim\u00E9 le droit de pr\u00E9f\u00E9rence des actionnaires pour l\u0027\u00E9mission de ces droits au personnel de la soci\u00E9t\u00E9, et a autoris\u00E9 une augmentation de capital en num\u00E9raire sous condition suspensive, \u00E0 hauteur du montant total des droits exerc\u00E9s. Ces d\u00E9cisions sont fond\u00E9es sur les articles 7:180, 7:191 et 7:198 du Code des soci\u00E9t\u00E9s et des",
  "co_filed_documents": [
    "une exp\u00E9dition du proc\u00E8s-verbal",
    "le plan de droits de souscription",
    "le rapport sp\u00E9cial du conseil d\u0027administration conform\u00E9ment aux articles 7:198 juncto 7:180 et 7:191 du Code des soci\u00E9t\u00E9s et des associations",
    "le rapport du commissaire \u00E9tabli en application des articles 7:198 juncto 7:180 et 7:191 du Code des soci\u00E9t\u00E9s et des associations"
  ],
  "detected_real_type": "other",
  "referenced_correction": null,
  "should_reroute_to_category": "capital_shares"
}

{
  "stage": null,
  "notary": {
    "name": "Tim CARNEWAL",
    "firm_city": null,
    "firm_name": "Berquin Notaires",
    "office_city": "Bruxelles",
    "is_associated": true
  },
  "act_meta": {
    "language": "fr",
    "pub_date": "2025-12-08",
    "filing_date": "2025-12-04",
    "act_kind_objet": "DIVERS"
  },
  "decision": {
    "body": "buitengewone_algemene_vergadering",
    "act_date": "2025-11-28",
    "unanimous": null
  },
  "conversion": null,
  "detected_kind": "other",
  "report_waiver": null,
  "restructuring": {
    "parties": [
      {
        "kbo": "0882.015.654",
        "name": "BioSenic",
        "role": "other",
        "address": "Avenue L\u00E9on Champagne 3, 1480 Tubize",
        "is_foreign": false,
        "legal_form": "Soci\u00E9t\u00E9 anonyme",
        "is_new_company": false,
        "jurisdiction_country": null
      }
    ],
    "exchange_ratio": null,
    "legal_articles": [
      "7:49"
    ],
    "is_cross_border": false,
    "is_silent_merger": false,
    "balance_basis_date": null,
    "exchange_ratio_text": null,
    "new_shares_issued_n": 0,
    "real_estate_included": false,
    "patrimony_description": "Le regroupement d\u0027actions concerne l\u0027ensemble des actions en circulation de la soci\u00E9t\u00E9 BioSenic, qui seront regroup\u00E9es \u00E0 raison d\u0027une nouvelle action pour dix mille actions existantes. Aucune r\u00E9duction ou augmentation du capital ne sera effectu\u00E9e.",
    "equity_transferred_eur": null,
    "accounting_effective_date": null
  },
  "subject_company": {
    "kbo": "0882.015.654",
    "name_full": "BioSenic",
    "legal_form": "Soci\u00E9t\u00E9 anonyme"
  },
  "publication_proxy": {
    "kind": "person",
    "org_kbo": null,
    "org_name": null,
    "person_name": "Tim CARNEWAL",
    "org_rep_person_name": null
  },
  "summary_narrative": "L\u0027assembl\u00E9e g\u00E9n\u00E9rale extraordinaire de la soci\u00E9t\u00E9 anonyme BioSenic, r\u00E9unie le 28 novembre 2025 \u00E0 Mont-Saint-Guibert, a adopt\u00E9 une r\u00E9solution autorisant le conseil d\u0027administration \u00E0 regrouper les actions en circulation de la soci\u00E9t\u00E9 \u00E0 raison d\u0027une nouvelle action pour dix mille actions existantes, sans modification du capital. Cette autorisation est valable trois ans et peut \u00EAtre exerc\u00E9e ou non selon les conditions du march\u00E9. Le conseil d\u0027administration dispose de pouvoirs \u00E9tendus pour mettre en \u0153uvre le regroupement, y compris la nomination d\u0027interm\u00E9diaires financiers, la gestion des fraction",
  "co_filed_documents": [
    "une exp\u00E9dition de l\u0027acte",
    "liste de pr\u00E9sences",
    "le proc\u00E8s-verbal de carence du 30 octobre 2025"
  ],
  "detected_real_type": "other",
  "referenced_correction": null,
  "should_reroute_to_category": "capital_shares"
}

{
  "events": [
    {
      "kind": "director_out",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Jean St\u00E9phenne",
        "address": null,
        "birth_date": null
      },
      "via_org": {
        "kbo": null,
        "name": "Innoste SA",
        "address": null,
        "country": null,
        "legal_form": null
      },
      "effective_date": "2025-10-09",
      "evidence_quote": "PRENNENT ACTE de la d\u00E9mission d\u0027Innoste SA, repr\u00E9sent\u00E9e par son repr\u00E9sentant permanent Monsieur Jean St\u00E9phenne, en tant (i) d\u0027administrateur de la Soci\u00E9t\u00E9 et (ii) pr\u00E9sident du conseil d\u0027administration, avec effet aux pr\u00E9sentes."
    },
    {
      "kind": "director_in",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Eric Halioua",
        "address": null,
        "birth_date": null
      },
      "via_org": {
        "kbo": null,
        "name": "CarKath SRL",
        "address": null,
        "country": null,
        "legal_form": null
      },
      "effective_date": "2025-10-09",
      "evidence_quote": "DECIDENT, conform\u00E9ment \u00E0 l\u0027article 7:88 du Code belge des soci\u00E9t\u00E9s et des associations (\u0022CSA\u0022) et \u00E0 l\u0027article 15 des statuts de la Soci\u00E9t\u00E9, de coopter CarKath SRL, repr\u00E9sent\u00E9e par son repr\u00E9sentant permanent, Monsieur Eric Halioua, n\u00E9 le [...] \u00E0 [...], ayant \u00E9lu domicile au si\u00E8ge de la Soci\u00E9t\u00E9, comme"
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0882.015.654",
    "name_full": "BIOSENIC",
    "legal_form": "SA"
  }
}

{
  "events": [
    {
      "kind": "director_in",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Anne-Sophie Jourdain",
        "address": null,
        "birth_date": null
      },
      "effective_date": "2025-07-01",
      "evidence_quote": "DECIDENT, conform\u00E9ment \u00E0 l\u0027article 7:88 du Code belge des soci\u00E9t\u00E9s et des associations et \u00E0 l\u0027article 15 des statuts de la Soci\u00E9t\u00E9, de coopter Madame Anne-Sophie Jourdain, n\u00E9e le [...] \u00E0 [...] comme nouvelle administratrice [...] de la Soci\u00E9t\u00E9 et ce avec effet au jour des pr\u00E9sentes r\u00E9solutions pour "
    },
    {
      "kind": "director_out",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Revital Rattenbach (Aflalo)",
        "address": null,
        "birth_date": null
      },
      "effective_date": "2025-07-01",
      "evidence_quote": "PRENNENT ACTE de la d\u00E9mission de Madame Revital Rattenbach (Aflalo) en tant d\u0027administratrice de la Soci\u00E9t\u00E9, avec effet aux pr\u00E9sentes."
    },
    {
      "kind": "director_in",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Revital Rattenbach (Aflalo)",
        "address": null,
        "birth_date": null
      },
      "via_org": {
        "kbo": null,
        "name": "Iryl Partners",
        "address": null,
        "country": null,
        "legal_form": null
      },
      "effective_date": "2025-07-01",
      "evidence_quote": "DECIDENT, conform\u00E9ment \u00E0 l\u0027article 7:88 du Code belge des soci\u00E9t\u00E9s et des associations et \u00E0 l\u0027article 15 des statuts de la Soci\u00E9t\u00E9, de coopter Iryl Partners, repr\u00E9sent\u00E9e par son repr\u00E9sentant permanent Madame Revital Rattenbach (Aflalo), comme nouvelle administratrice [...] de la Soci\u00E9t\u00E9 et ce avec e"
    },
    {
      "kind": "director_in",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Seppe De Gelas",
        "address": null,
        "birth_date": null
      },
      "via_org": {
        "kbo": null,
        "name": "Boletus Consulting BV",
        "address": null,
        "country": null,
        "legal_form": null
      },
      "effective_date": "2025-08-04",
      "evidence_quote": "Le conseil d\u0027administration a d\u00E9cid\u00E9, conform\u00E9ment \u00E0 l\u0027article 7:88 du CSA et \u00E0 l\u0027article 15 des statuts de la Soci\u00E9t\u00E9, de coopter Boletus Consulting BV, repr\u00E9sent\u00E9e par son repr\u00E9sentant permanent, M. Seppe De Gelas, n\u00E9 le [...] \u00E0 [...], ayant \u00E9lu domicile au si\u00E8ge de la Soci\u00E9t\u00E9, en tant que nouvel "
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0882.015.654",
    "name_full": "BIOSENIC",
    "legal_form": "SA"
  }
}

{
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "statute_change": {
    "name_change": false,
    "seat_change": false,
    "object_change": false,
    "effective_date": "2025-04-04",
    "legal_form_change": false
  },
  "bedrijfsrevisor": null,
  "subject_company": {
    "kbo": "0882.015.654",
    "name_full": "BIOSENIC",
    "legal_form": "SA"
  },
  "signature_regime": null,
  "special_mandates": [],
  "governance_change": {
    "admin_delegated_added": []
  }
}

{
  "events": [
    {
      "kind": "capital_increase",
      "amount": 100000.0,
      "currency": "EUR",
      "after_eur": 38300668.63,
      "delta_eur": 100000.0,
      "before_eur": 38200668.63,
      "amount_type": "kapitaal_effectief",
      "effective_date": "2025-03-26",
      "evidence_quote": "Le capital est augment\u00E9 \u00E0 concurrence de 100.000,00 EUR. ... Le capital a \u00E9t\u00E9 augment\u00E9 \u00E0 concurrence de 100.000,00 EUR et port\u00E9 de 38.200.668,63 EUR \u00E0 38.300.668,63 EUR. ... Lesdites nouvelles actions ont \u00E9t\u00E9 souscrites en esp\u00E8ces",
      "contribution_type": "cash"
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0882.015.654",
    "name_full": "BIOSENIC",
    "legal_form": "SA"
  }
}

{
  "events": [
    {
      "kind": "capital_increase",
      "amount": 100000.0,
      "currency": "EUR",
      "after_eur": 38100668.63,
      "delta_eur": 100000.0,
      "before_eur": 38000668.63,
      "amount_type": "kapitaal_effectief",
      "effective_date": "2025-03-05",
      "evidence_quote": "Le capital est augment\u00E9 \u00E0 concurrence de 100.000,00 EUR. ... Le capital a \u00E9t\u00E9 augment\u00E9 \u00E0 concurrence de 100.000,00 EUR et port\u00E9 de 38.000.668,63 EUR \u00E0 38.100.668,63 EUR. ... Lesdites nouvelles actions ont \u00E9t\u00E9 souscrites en esp\u00E8ces",
      "contribution_type": "cash"
    },
    {
      "kind": "capital_increase",
      "amount": 100000.0,
      "currency": "EUR",
      "after_eur": 38200668.63,
      "delta_eur": 100000.0,
      "before_eur": 38100668.63,
      "amount_type": "kapitaal_effectief",
      "effective_date": "2025-03-14",
      "evidence_quote": "Le capital est augment\u00E9 \u00E0 concurrence de 100.000,00 EUR. ... Le capital a \u00E9t\u00E9 augment\u00E9 \u00E0 concurrence de 100.000,00 EUR et port\u00E9 de 38.100.668,63 EUR \u00E0 38.200.668,63 EUR. ... Lesdites nouvelles actions ont \u00E9t\u00E9 souscrites en esp\u00E8ces",
      "contribution_type": "cash"
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0882.015.654",
    "name_full": "BIOSENIC",
    "legal_form": "SA"
  }
}

{
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "statute_change": {
    "name_change": false,
    "seat_change": false,
    "object_change": false,
    "effective_date": "2025-02-17",
    "legal_form_change": false
  },
  "bedrijfsrevisor": null,
  "subject_company": {
    "kbo": "0882.015.654",
    "name_full": "BIOSENIC",
    "legal_form": "SA"
  },
  "signature_regime": null,
  "special_mandates": [],
  "governance_change": {
    "admin_delegated_added": []
  }
}

{
  "events": [
    {
      "kind": "capital_increase",
      "amount": 100000.0,
      "currency": "EUR",
      "after_eur": 37800668.63,
      "delta_eur": 100000.0,
      "before_eur": 37700668.63,
      "amount_type": "kapitaal_effectief",
      "effective_date": "2025-01-31",
      "evidence_quote": "Le capital est augment\u00E9 \u00E0 concurrence de 100.000,00 EUR. ... Le capital a \u00E9t\u00E9 augment\u00E9 \u00E0 concurrence de 100.000,00 EUR et port\u00E9 de 37.700.668,63 EUR \u00E0 37.800.668,63 EUR. ... Lesdites nouvelles actions ont \u00E9t\u00E9 souscrites en esp\u00E8ces",
      "contribution_type": "cash"
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0882.015.654",
    "name_full": "BIOSENIC",
    "legal_form": "SA"
  }
}

{
  "events": [
    {
      "kind": "capital_increase",
      "amount": 100000.0,
      "currency": "EUR",
      "after_eur": 37500668.63,
      "delta_eur": 100000.0,
      "before_eur": 37400668.63,
      "amount_type": "kapitaal_effectief",
      "effective_date": "2025-01-03",
      "evidence_quote": "Le capital est augment\u00E9 \u00E0 concurrence de 100.000,00 EUR. ... Le capital a \u00E9t\u00E9 augment\u00E9 \u00E0 concurrence de 100.000,00 EUR et port\u00E9 de 37.400.668,63 EUR \u00E0 37.500.668,63 EUR. ... Lesdites nouvelles actions ont \u00E9t\u00E9 souscrites en esp\u00E8ces",
      "contribution_type": "cash"
    },
    {
      "kind": "capital_increase",
      "amount": 100000.0,
      "currency": "EUR",
      "after_eur": 37600668.63,
      "delta_eur": 100000.0,
      "before_eur": 37500668.63,
      "amount_type": "kapitaal_effectief",
      "effective_date": "2025-01-08",
      "evidence_quote": "Le capital est augment\u00E9 \u00E0 concurrence de 100.000,00 EUR. ... Le capital a \u00E9t\u00E9 augment\u00E9 \u00E0 concurrence de 100.000,00 EUR et port\u00E9 de 37.500.668,63 EUR \u00E0 37.600.668,63 EUR. ... Lesdites nouvelles actions ont \u00E9t\u00E9 souscrites en esp\u00E8ces",
      "contribution_type": "cash"
    },
    {
      "kind": "capital_increase",
      "amount": 100000.0,
      "currency": "EUR",
      "after_eur": 37700668.63,
      "delta_eur": 100000.0,
      "before_eur": 37600668.63,
      "amount_type": "kapitaal_effectief",
      "effective_date": "2025-01-21",
      "evidence_quote": "Le capital est augment\u00E9 \u00E0 concurrence de 100.000,00 EUR. ... Le capital a \u00E9t\u00E9 augment\u00E9 \u00E0 concurrence de 100.000,00 EUR et port\u00E9 de 37.600.668,63 EUR \u00E0 37.700.668,63 EUR. ... Lesdites nouvelles actions ont \u00E9t\u00E9 souscrites en esp\u00E8ces",
      "contribution_type": "cash"
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0882.015.654",
    "name_full": "BIOSENIC",
    "legal_form": "SA"
  }
}

{
  "events": [
    {
      "kind": "capital_increase",
      "amount": 200000.0,
      "currency": "EUR",
      "after_eur": 37400668.63,
      "delta_eur": 200000.0,
      "before_eur": 37200668.63,
      "amount_type": "kapitaal_effectief",
      "effective_date": "2024-12-12",
      "evidence_quote": "Le capital est augment\u00E9 \u00E0 concurrence de 200.000,00 EUR. ... Le capital a \u00E9t\u00E9 augment\u00E9 \u00E0 concurrence de 200.000,00 EUR et port\u00E9 de 37.200.668,63 EUR \u00E0 37.400.668,63 EUR. ... Lesdites nouvelles actions ont \u00E9t\u00E9 souscrites en esp\u00E8ces",
      "contribution_type": "cash"
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0882.015.654",
    "name_full": "BIOSENIC",
    "legal_form": "SA"
  }
}

{
  "events": [
    {
      "kind": "capital_increase",
      "amount": 50000.0,
      "currency": "EUR",
      "after_eur": 37200668.63,
      "delta_eur": 50000.0,
      "before_eur": 37150668.63,
      "amount_type": "kapitaal_effectief",
      "effective_date": "2024-11-27",
      "evidence_quote": "Le capital est augment\u00E9 \u00E0 concurrence de 50.000,00 EUR. ... Le capital a \u00E9t\u00E9 augment\u00E9 \u00E0 concurrence de 50.000,00 EUR et port\u00E9 de 37.150.668,63 EUR \u00E0 37.200.668,63 EUR. ... Lesdites nouvelles actions ont \u00E9t\u00E9 souscrites en esp\u00E8ces",
      "contribution_type": "cash"
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0882.015.654",
    "name_full": "BIOSENIC",
    "legal_form": "SA"
  }
}

{
  "events": [
    {
      "kind": "capital_increase",
      "amount": 50000.0,
      "currency": "EUR",
      "after_eur": 37150668.63,
      "delta_eur": 50000.0,
      "before_eur": 37100668.63,
      "amount_type": "kapitaal_effectief",
      "effective_date": "2024-11-15",
      "evidence_quote": "Le capital est augment\u00E9 \u00E0 concurrence de 50.000,00 EUR.",
      "contribution_type": "cash"
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0882.015.654",
    "name_full": "BIOSENIC",
    "legal_form": "SA"
  }
}

{
  "events": [
    {
      "kind": "director_in",
      "role": "gedelegeerd_bestuurder",
      "person": {
        "rrn": null,
        "name": "Jean-Luc Vandebroek",
        "address": null,
        "birth_date": null
      },
      "via_org": {
        "kbo": null,
        "name": "Finsys Management SRL",
        "address": null,
        "country": null,
        "legal_form": null
      },
      "effective_date": "2024-09-27",
      "evidence_quote": "DECIDE d\u0027accorder \u00E0 Finsys Management SRL, repr\u00E9sent\u00E9e par son repr\u00E9sentant permanent Jean-Luc Vandebroek, les pouvoirs de repr\u00E9senter la Soci\u00E9t\u00E9 vis-\u00E0-vis des tiers et l\u00E9galement dans le cadre de la gestion journali\u00E8re des activit\u00E9s, avec effet imm\u00E9diat."
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0882.015.654",
    "name_full": "BIOSENIC",
    "legal_form": "SA"
  }
}

{
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "statute_change": {
    "name_change": false,
    "seat_change": false,
    "object_change": false,
    "effective_date": "2024-10-02",
    "legal_form_change": false
  },
  "bedrijfsrevisor": null,
  "subject_company": {
    "kbo": "0882.015.654",
    "name_full": "BIOSENIC",
    "legal_form": "SA"
  },
  "signature_regime": null,
  "special_mandates": [],
  "governance_change": {
    "admin_delegated_added": []
  }
}

{
  "stage": null,
  "notary": {
    "name": "Tim CARNEWAL",
    "firm_city": null,
    "firm_name": "Berquin Notaires",
    "office_city": "Bruxelles",
    "is_associated": true
  },
  "act_meta": {
    "language": "fr",
    "pub_date": "2024-07-30",
    "filing_date": "2024-07-26",
    "act_kind_objet": "DIVERS"
  },
  "decision": {
    "body": "raad_van_bestuur",
    "act_date": "2024-07-12",
    "unanimous": null
  },
  "conversion": null,
  "detected_kind": "other",
  "report_waiver": null,
  "restructuring": {
    "parties": [
      {
        "kbo": "0882.015.654",
        "name": "BioSenic",
        "role": "other",
        "address": "Rue Granbonpr\u00E9 11, 1435 Mont-Saint-Guibert",
        "is_foreign": false,
        "legal_form": "Soci\u00E9t\u00E9 anonyme",
        "is_new_company": false,
        "jurisdiction_country": null
      }
    ],
    "exchange_ratio": null,
    "legal_articles": [
      "7:180",
      "7:191",
      "7:193",
      "7:187"
    ],
    "is_cross_border": false,
    "is_silent_merger": false,
    "balance_basis_date": null,
    "exchange_ratio_text": null,
    "new_shares_issued_n": 0,
    "real_estate_included": false,
    "patrimony_description": "\u00C9mission de 210 obligations convertibles d\u0027une valeur nominale de 10.000 EUR chacune, totalisant 2.100.000 EUR. Les obligations sont \u00E9mises sous condition suspensive de souscription et de lib\u00E9ration int\u00E9grale. Une partie (30 obligations) est d\u00E9j\u00E0 souscrite et lib\u00E9r\u00E9e. Le capital sera augment\u00E9 \u00E0 la conversion des obligations, avec \u00E9mission de nouvelles actions au profit des d\u00E9tenteurs.",
    "equity_transferred_eur": null,
    "accounting_effective_date": null
  },
  "subject_company": {
    "kbo": "0882.015.654",
    "name_full": "BioSenic",
    "legal_form": "Soci\u00E9t\u00E9 anonyme"
  },
  "detected_kind_raw": "capital_shares",
  "publication_proxy": {
    "kind": "person",
    "org_kbo": null,
    "org_name": null,
    "person_name": "Tim CARNEWAL",
    "org_rep_person_name": null
  },
  "summary_narrative": "Le conseil d\u0027administration de BioSenic, soci\u00E9t\u00E9 anonyme, a d\u00E9cid\u00E9 d\u0027\u00E9mettre jusqu\u0027\u00E0 210 obligations convertibles d\u0027une valeur nominale de 10.000 EUR chacune, pour un montant total maximum de 2.100.000 EUR, sous condition suspensive de souscription et de lib\u00E9ration int\u00E9grale. Une partie de ces obligations (30) a d\u00E9j\u00E0 \u00E9t\u00E9 souscrite et lib\u00E9r\u00E9e. L\u0027augmentation du capital sera r\u00E9alis\u00E9e \u00E0 la conversion des obligations, avec \u00E9mission de nouvelles actions. Le conseil a \u00E9galement attribu\u00E9 des pouvoirs aux administrateurs et \u00E0 des mandataires sp\u00E9ciaux pour assurer la mise en \u0153uvre de l\u0027op\u00E9ration, y com",
  "co_filed_documents": [
    "une exp\u00E9dition de l\u0027acte",
    "le rapport sp\u00E9cial du conseil d\u0027administration",
    "le rapport du commissaire \u00E9tabli en application des articles 7:198 juncto 7:180, 7:191 et 7:193 du Code des soci\u00E9t\u00E9s et des associations"
  ],
  "detected_real_type": "other",
  "referenced_correction": null,
  "should_reroute_to_category": "capital_shares"
}

{
  "events": [
    {
      "kind": "director_out",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Yves Sagot",
        "address": null,
        "birth_date": null
      },
      "evidence_quote": "DECIDENT de prendre acte de la d\u00E9mission de Monsieur Yves Sagot, n\u00E9 le [...] \u00E0 [...), et ayant \u00E9lu domicile pour toutes questions relatives \u00E0 son mandat d\u0027administrateur au si\u00E8ge de la Soci\u00E9t\u00E9, en tant qu\u0027administrateur ind\u00E9pendant de la Soci\u00E9t\u00E9 avec effet \u00E0 l\u0027assembl\u00E9e g\u00E9n\u00E9rale ordinaire 2024 de la"
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0882.015.654",
    "name_full": "BIOSENIC",
    "legal_form": "SA"
  }
}

{
  "events": [
    {
      "kind": "capital_increase",
      "amount": 350000.0,
      "currency": "EUR",
      "after_eur": 37000668.63,
      "delta_eur": 350000.0,
      "before_eur": 36650668.63,
      "amount_type": "kapitaal_effectief",
      "effective_date": "2024-06-25",
      "evidence_quote": "Le capital est augment\u00E9 \u00E0 concurrence de 350.000,00 EUR.",
      "contribution_type": "cash"
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0882.015.654",
    "name_full": "BIOSENIC",
    "legal_form": "SA"
  }
}

{
  "events": [
    {
      "kind": "capital_increase",
      "amount": 100000.0,
      "currency": "EUR",
      "after_eur": 36650668.63,
      "delta_eur": 100000.0,
      "before_eur": 36550668.63,
      "amount_type": "kapitaal_effectief",
      "effective_date": "2024-05-29",
      "evidence_quote": "Le capital est augment\u00E9 \u00E0 concurrence de 100.000,00 EUR. ... Le capital a \u00E9t\u00E9 augment\u00E9 \u00E0 concurrence de 100.000,00 EUR et port\u00E9 de 36.550.668,63 EUR \u00E0 36.650.668,63 EUR. ... Lesdites nouvelles actions ont \u00E9t\u00E9 souscrites en esp\u00E8ces",
      "contribution_type": "cash"
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0882.015.654",
    "name_full": "BIOSENIC",
    "legal_form": "SA"
  }
}

{
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "statute_change": {
    "name_change": false,
    "seat_change": false,
    "object_change": false,
    "effective_date": "2024-05-27",
    "legal_form_change": false
  },
  "bedrijfsrevisor": null,
  "subject_company": {
    "kbo": "0882.015.654",
    "name_full": "BIOSENIC",
    "legal_form": "SA"
  },
  "signature_regime": null,
  "special_mandates": [],
  "governance_change": {
    "admin_delegated_added": []
  }
}

{
  "events": [
    {
      "kind": "capital_increase",
      "amount": 350000.0,
      "currency": "EUR",
      "after_eur": 36450668.63,
      "delta_eur": 350000.0,
      "before_eur": 36100668.63,
      "amount_type": "kapitaal_effectief",
      "effective_date": "2024-04-26",
      "evidence_quote": "Le capital est augment\u00E9 \u00E0 concurrence de 350.000,00 EUR. ... Le capital a \u00E9t\u00E9 augment\u00E9 \u00E0 concurrence de 350.000,00 EUR et port\u00E9 de 36.100.668,63 EUR \u00E0 36.450.668,63 EUR. ... Lesdites nouvelles actions ont \u00E9t\u00E9 souscrites en esp\u00E8ces",
      "contribution_type": "cash"
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0882.015.654",
    "name_full": "BIOSENIC",
    "legal_form": "SA"
  }
}

{
  "notary": {
    "name": "Tim CARNEWAL",
    "firm_city": null,
    "firm_name": "Berquin Notaires",
    "office_city": "Bruxelles",
    "is_associated": true
  },
  "act_meta": {
    "language": "nl",
    "pub_date": "2024-05-03",
    "filing_date": "2024-04-30",
    "act_kind_objet": "DIVERS"
  },
  "decision": {
    "body": "notarieel_alleen",
    "date": "2024-04-19",
    "unanimous": null
  },
  "agm_change": null,
  "detected_kind": "other",
  "other_address": null,
  "mandate_renewal": null,
  "subject_company": {
    "kbo": "0882.015.654",
    "name_full": "BioSenic",
    "legal_form": "SA"
  },
  "accounts_deposit": null,
  "publication_proxy": {
    "kind": "none",
    "org_kbo": null,
    "org_name": null,
    "person_name": null,
    "org_rep_person_name": null
  },
  "co_filed_documents": [
    "une exp\u00E9dition de l\u2019acte"
  ],
  "fiscal_year_change": null,
  "liquidation_closure": null,
  "officer_designation": null,
  "special_procuration": null,
  "is_volet_a_only_stub": false,
  "vakbekwaamheid_change": null,
  "should_reroute_to_category": null,
  "single_shareholder_declaration": null
}

{
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "statute_change": {
    "name_change": false,
    "seat_change": false,
    "object_change": false,
    "effective_date": "2024-04-16",
    "legal_form_change": false
  },
  "bedrijfsrevisor": null,
  "subject_company": {
    "kbo": "0882.015.654",
    "name_full": "BIOSENIC",
    "legal_form": "SA"
  },
  "signature_regime": null,
  "special_mandates": [],
  "governance_change": {
    "admin_delegated_added": []
  }
}

{
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "statute_change": {
    "name_change": false,
    "seat_change": false,
    "object_change": false,
    "effective_date": "2024-03-21",
    "legal_form_change": false
  },
  "bedrijfsrevisor": null,
  "subject_company": {
    "kbo": "0882.015.654",
    "name_full": "BIOSENIC",
    "legal_form": "SA"
  },
  "signature_regime": null,
  "special_mandates": [],
  "governance_change": {
    "admin_delegated_added": []
  }
}

{
  "events": [
    {
      "kind": "capital_increase",
      "amount": 100000.0,
      "currency": "EUR",
      "after_eur": 35950668.63,
      "delta_eur": 100000.0,
      "before_eur": 35850668.63,
      "amount_type": "kapitaal_effectief",
      "effective_date": "2024-03-18",
      "evidence_quote": "Le capital est augment\u00E9 \u00E0 concurrence de 100.000,00 EUR.",
      "contribution_type": "cash"
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0882.015.654",
    "name_full": "BIOSENIC",
    "legal_form": "SA"
  }
}

{
  "stage": null,
  "notary": {
    "name": "Tim CARNEWAL",
    "firm_city": null,
    "firm_name": "Berquin Notaires",
    "office_city": "Bruxelles",
    "is_associated": true
  },
  "act_meta": {
    "language": "fr",
    "pub_date": "2024-03-21",
    "filing_date": "2024-03-19",
    "act_kind_objet": "DIVERS"
  },
  "decision": {
    "body": "raad_van_bestuur",
    "act_date": "2024-03-15",
    "unanimous": null
  },
  "conversion": null,
  "detected_kind": "other",
  "report_waiver": null,
  "restructuring": {
    "parties": [
      {
        "kbo": "0882.015.654",
        "name": "BioSenic",
        "role": "contributor",
        "address": "Rue Granbonpr\u00E9 11, 1435 Mont-Saint-Guibert, Building H",
        "is_foreign": false,
        "legal_form": "Soci\u00E9t\u00E9 anonyme",
        "is_new_company": false,
        "jurisdiction_country": "BE"
      },
      {
        "kbo": null,
        "name": "l\u0027Investisseur",
        "role": "recipient",
        "address": null,
        "is_foreign": false,
        "legal_form": null,
        "is_new_company": false,
        "jurisdiction_country": "BE"
      }
    ],
    "exchange_ratio": null,
    "legal_articles": [
      "12:7",
      "12:50"
    ],
    "is_cross_border": false,
    "is_silent_merger": false,
    "balance_basis_date": null,
    "exchange_ratio_text": null,
    "new_shares_issued_n": 0,
    "real_estate_included": false,
    "patrimony_description": "L\u0027apport en num\u00E9raire, soit le prix d\u0027\u00E9mission des Nouvelles Obligations Convertibles, a \u00E9t\u00E9 effectu\u00E9 par l\u0027investisseur via un virement bancaire. Le montant total de 300.000,00 EUR a \u00E9t\u00E9 enti\u00E8rement lib\u00E9r\u00E9 et mis \u00E0 disposition de la soci\u00E9t\u00E9.",
    "equity_transferred_eur": 300000.0,
    "accounting_effective_date": null
  },
  "subject_company": {
    "kbo": "0882.015.654",
    "name_full": "BioSenic",
    "legal_form": "Soci\u00E9t\u00E9 anonyme"
  },
  "publication_proxy": {
    "kind": "person",
    "org_kbo": null,
    "org_name": null,
    "person_name": "Tim CARNEWAL",
    "org_rep_person_name": null
  },
  "summary_narrative": "Le 15 mars 2024, la soci\u00E9t\u00E9 anonyme BioSenic a re\u00E7u un apport en num\u00E9raire de 300.000,00 EUR sous forme de 30 Nouvelles Obligations Convertibles, enti\u00E8rement lib\u00E9r\u00E9es par virement bancaire. L\u0027investisseur a exerc\u00E9 son droit de pr\u00E9f\u00E9rence et a souscrit \u00E0 ces obligations conform\u00E9ment aux modalit\u00E9s \u00E9tablies par le conseil d\u0027administration.",
  "co_filed_documents": [
    "une exp\u00E9dition de l\u0027acte"
  ],
  "detected_real_type": "other",
  "referenced_correction": null,
  "should_reroute_to_category": "capital_shares"
}

{
  "events": [
    {
      "kind": "capital_increase",
      "amount": 50000.0,
      "currency": "EUR",
      "after_eur": 35850668.63,
      "delta_eur": 50000.0,
      "before_eur": 35800668.63,
      "amount_type": "kapitaal_effectief",
      "effective_date": "2024-02-26",
      "evidence_quote": "Le capital est augment\u00E9 \u00E0 concurrence de 50.000,00 EUR.",
      "contribution_type": "cash"
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0882.015.654",
    "name_full": "BIOSENIC",
    "legal_form": "SA"
  }
}

{
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "statute_change": {
    "name_change": false,
    "seat_change": false,
    "object_change": false,
    "effective_date": "2024-02-22",
    "legal_form_change": false
  },
  "bedrijfsrevisor": null,
  "subject_company": {
    "kbo": "0882.015.654",
    "name_full": "BIOSENIC",
    "legal_form": "SA"
  },
  "signature_regime": null,
  "special_mandates": [],
  "governance_change": {
    "admin_delegated_added": []
  }
}

{
  "events": [
    {
      "kind": "capital_increase",
      "amount": 499999.92,
      "currency": "EUR",
      "after_eur": 35700668.63,
      "delta_eur": 499999.92,
      "before_eur": 35200668.71,
      "amount_type": "kapitaal_effectief",
      "effective_date": "2024-02-06",
      "evidence_quote": "Il r\u00E9sulte de ce qui pr\u00E9c\u00E8de que le capital est effectivement augment\u00E9 \u00E0 concurrence d\u2019un montant total de 499.999,92 EUR et est port\u00E9 de 35.200.668,71 EUR \u00E0 35.700.668,63 EUR et que cette augmentation du capital par apport en num\u00E9raire est accompagn\u00E9e de l\u0027\u00E9mission de 12.195.120 nouvelles actions",
      "contribution_type": "cash"
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0882.015.654",
    "name_full": "BIOSENIC",
    "legal_form": "SA"
  }
}